http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-T77806-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c17b4872eb33eb876830bd26395018cf |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-35 |
| filingDate | 1994-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4dc743a1f1c0c77af90ad4ab3c8627d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dba71f611201510b2f0b1e8689ab7ba1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4383bcd27a4dfdbeedbbd03d172b12c |
| publicationDate | 1998-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | HU-T77806-A |
| titleOfInvention | Antigen-specific immune response under-regulating peptide formulations |
| abstract | Therapeutic compsns. as follows are claimed: compsn. 1 comprising at least one isolated peptide having a defined sequence of amino acid residues, the compsn. being capable of down-regulating an antigen specific immune response (ASIR) in a population of humans subject to the ASIR, when administered in non-immunogenic form; and compsn. 2 comprising at least one isolated and purified peptide having a defined length, a defined sequence of amino acid residues and comprising at least one T cell epitope of a protein antigen, the compsn. being capable of down-regulating an ASIR to the protein antigen in a population of humans subject to the ASIR when administered in non-immunogenic form. |
| priorityDate | 1994-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 279.